Search results
Vedanta Biosciences doses first subject in Phase III C difficile prevention trial
Clinical Trials Arena via Yahoo Finance· 3 weeks agoVedanta Biosciences has dosed the first subject in Phase III RESTORATiVE303 clinical trial of VE303,...